Read time: 1 minute

U.S. Owns Patent Rights To Remdesivir, But Is Content To Let Gilead Jack Up Prices

"I think that we need more companies making it, so we have enough drug for the people who need it and so that the price can be driven down so that people can afford it," Dr. Rochelle Walensky said.
Views:

On CNN's New Day, John Berman asked Dr. Rochelle Walensky, an infectious disease specialist at Massachusetts General, what she's hearing from colleagues in Texas about getting an adequate supply of remdesivir to treat coronavirus patients.

"I certainly am," she said.

"I see three problems with remdesivir right now. One is, a single manufacturer is making it, Gilead. Two, it is that we are going to run out. I think you can't look at the number of cases that are happening right now and not anticipate a shortage. And three, last week, it was priced at over $3,000 for a five-day course for a drug that we know costs $6 for a five-day course to make.

"So HHS has the power and the patent rights to this drug. I think we need generic competition. I think that we need more companies making it, so we have enough drug for the people who need it and so that the price can be driven down so that people can afford it."

Funny, isn't it? Trump doesn't care about what serves sick people. Quite consistently, he puts his thumb on the scale for Big Pharma.

We Need Your Help Now More Than Ever

For 17 years we have been exposing Washington lies and untangling media deceit, but now Facebook and social media are drowning us in an ocean of right wing lies. Please give a one-time or recurring donation, or subscribe for an ad-free experience.

More C&L Coverage

Discussion

New Commenting System

Our comments are now powered by Insticator. In order to comment you will need to create an Insticator account. The process is quick and simple. Please note that the ability to comment with a C&L site account is no longer available.

We welcome relevant, respectful comments. Any comments that are sexist or in any other way deemed hateful by our staff will be deleted and constitute grounds for a ban from posting on the site. Please refer to our Terms of Service (revised 3/17/2016) for information on our posting policy.

Please Do Not Use the Login Link at the Top of the Site.

In order to comment you must use an Insticator account. To register an account, enter your comment and click the post button. A dialog will then appear allowing you create your account.

We will be retiring our Crooks and Liars user account system in January, 2021.

Thank you.
C&L Team